文献速递精神分裂症与精神病性障碍

犬尿喹啉酸促进精神分裂症中活动依赖性突触消除

Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia.
PubMed 文献 · Am J Psychiatry · 2025-01-01

研究利用患者来源的诱导多能干细胞构建二维神经元与小胶质细胞样细胞培养及前脑类器官,测试犬尿喹啉酸(KYNA)通过降低神经元活动诱导小胶质细胞吞噬突触的假说。结果显示KYNA诱导小胶质细胞摄取突触结构,抑制内源性KYNA产生减少突触内化;大规模转录组与遗传数据集显示KYNA生成酶KATs富集突触活动相关基因及精神分裂症遗传风险变异。结论将精神分裂症遗传风险变异与KYNA生成升高及小胶质细胞活动依赖性突触内化联系起来,并提示药理学抑制KATs作为避免突触丢失的策略。

要点

  • 患者来源模型显示KYNA诱导小胶质细胞摄取突触结构。
  • 抑制内源性KYNA产生减少小胶质细胞突触内化。
  • KYNA生成酶KATs富集突触活动基因及精神分裂症风险变异。

核心结论

  • 结果将精神分裂症遗传风险变异与KYNA生成升高及小胶质细胞过度且活动依赖性的突触物质内化联系起来。
  • 作者认为药理学抑制KATs可作为避免精神分裂症突触丢失的策略。

研究设计与样本

  • 使用患者来源诱导多能干细胞生成二维神经元与小胶质细胞样细胞培养及固有发育小胶质细胞的前脑类器官。
  • 使用大规模发育期死后脑组织与遗传数据集研究KYNA生成酶KATs的共表达网络。

主要发现

  • 在患者来源实验模型中,KYNA诱导小胶质细胞摄取突触结构。
  • 抑制内源性KYNA产生导致小胶质细胞突触内化减少。
  • 整合大规模转录组与遗传数据集显示KYNA生成酶KATs富集调控突触活动的基因及精神分裂症遗传风险变异。

临床怎么用

  • 作者认为药理学抑制KATs是避免精神分裂症突触丢失的策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Schizophrenia is a neurodevelopmental disorder characterized by an excessive loss of synapses. Kynurenic acid (KYNA), a neuroactive metabolite of tryptophan along the kynurenine pathway, can induce schizophrenia-related phenotypes in rodents, and clinical studies have revealed elevated KYNA levels in the CNS of individuals with schizophrenia. However, the factors that cause elevated KYNA levels in schizophrenia, and the mechanisms by which KYNA contributes to pathophysiology, remain largely elusive. The authors used patient-derived cellular modeling to test the hypothesis that KYNA can induce microglia-mediated synapse engulfment by reducing neuronal activity. METHODS: Patient-derived induced pluripotent stem cells were used to generate 2D cultures of neurons and microglia-like cells, as well as forebrain organoids with innately developing microglia, to study how KYNA influences synaptic activity and microglial uptake of synaptic structures. To verify the experimental data in a clinical context, large-scale developmental postmortem brain tissue and genetic datasets were used to study coexpression networks for the KYNA-producing kynurenine aminotransferases (KATs) regarding enrichment for common schizophrenia genetic risk variants and functional annotations. RESULTS: In these patient-derived experimental models, KYNA induced uptake of synaptic structures in microglia, and inhibition of the endogenous KYNA production led to a decrease in the internalization of synapses in microglia. The integrated large-scale transcriptomic and genetic datasets showed that KYNA-producing KATs enriched for genes governing synaptic activity and genetic risk variants for schizophrenia. CONCLUSIONS: Together, these results link genetic risk variants for schizophrenia to elevated production of KYNA and excessive and activity-dependent internalization of synaptic material in microglia, while implicating pharmacological inhibition of KATs as a strategy to avoid synapse loss in schizophrenia.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Orhan F, Malwade S, Khanlarkhani N, et al. Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia. Am J Psychiatry. 2025. PMID: 40165559. doi:10.1176/appi.ajp.20240048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。